Nukkleus Inc

Nukkleus Inc. (NASDAQ: NUKK) is a financial technology company. The Company is focused on providing software and technology solutions for the worldwide retail foreign exchange (FX) trading industry. The Company primarily provides its software, technology, customer sales and marketing and risk management technology hardware and software solutions package to Triton Capital Markets Ltd.

Key Business and Financial Updates:

• Strategic Expansion into Artificial Intelligence and Defense Technologies: During 2025, Nukkleus undertook targeted strategic initiatives aimed at expanding its exposure to advanced artificial intelligence and defense-related technologies. On July 30, 2025, the Company entered into a warrant agreement with Synthetic Darwin LLC, granting rights to acquire up to 200 million Darwin tokens, representing a new class of self-evolving AI network assets. Darwin’s platform is designed to simulate and optimize complex scenarios across financial services, healthcare, and defense applications. As of the reporting date, Nukkleus holds 100 million Darwin tokens, positioning the Company to leverage AI-driven scenario modeling capabilities across its existing and prospective subsidiaries.
• Entry into U.S. Defense and Homeland Security Distribution Markets: On August 20, 2025, Nukkleus secured exclusive U.S. distribution rights for BladeRanger Ltd.’s advanced drone payload systems within the defense and homeland security markets. BladeRanger, founded in 1968, reported revenue growth of 237% in 2024 and specializes in autonomous drone navigation hardware and software with patent-pending technologies. The agreement includes defined minimum purchase commitments over a three-year period and provides for an automatic five-year extension upon fulfillment. As of the reporting date, no payload purchases have been executed, indicating that commercial activity under this agreement remains in the early stages.
• Revenue Disruption and Dependence on Pending Acquisitions: For the three and nine months ended September 30, 2025, the Company reported no revenue from continuing operations, reflecting the discontinuation and subsequent deconsolidation of its DRFQ subsidiary in July 2025. Management has indicated that future revenue generation is expected to commence upon the anticipated closings of the Star and Tiltan acquisitions, which are targeted for completion near the end of the fourth quarter of 2025. Until these transactions are finalized, the Company does not expect to generate material revenue from alternative operating sources.
• Elevated Operating Expenses Driven by Transaction-Related Costs: Operating expenses increased sharply during the reporting period, driven primarily by professional fees associated with consulting, audit, and transaction-related activities. Professional fees rose by approximately USD 3.8 million year-on-year in the third quarter of 2025, largely reflecting consulting expenses linked to equity issuances and warrant grants associated with a new joint venture arrangement executed in August 2025. Management has stated that these expenses are largely non-recurring in nature and expects professional fees to normalize following the completion of the Star acquisition and the reduction of one-time advisory and issuance-related costs.
• Liquidity Profile, Non-Cash Earnings, and Capital Structure Dynamics: For the nine months ended September 30, 2025, Nukkleus reported pre-tax net income of approximately USD 90.1 million; however, this result was driven predominantly by non-cash gains related to fair value adjustments on liability-classified warrants and derivative instruments, rather than operating cash generation. Despite reported profitability, the Company maintained a working capital deficit of USD 30.5 million, with cash and cash equivalents totaling USD 7.6 million at quarter-end. Operating cash flow remained negative at approximately USD 5.2 million year-to-date, while investing cash outflows were primarily attributable to USD 3.5 million in advance payments related to the planned Star acquisition. Financing activities provided net inflows of USD 8.3 million, underscoring continued reliance on external capital to fund operations and strategic initiatives.

Key Company specific risks for NUKK:

• Revenue Visibility Risk: NUKK currently generates no revenue from continuing operations and remains dependent on the successful and timely closure of the Star and Tiltan acquisitions, expected near the end of Q4 2025, to begin meaningful revenue generation.
• Earnings Quality and Volatility Risk: Reported profitability in 2025 was largely driven by non-cash fair value gains on warrants and derivatives rather than operating performance, introducing significant earnings volatility and limiting visibility into sustainable cash-based profitability.
• Liquidity and Funding Risk: The Company continues to operate with a sizeable working capital deficit (~USD 30.5 million) and modest cash balance (~USD 7.6 million), implying ongoing reliance on external financing and exposing shareholders to dilution and refinancing risk.

Technical Observation (on the daily chart):

• Trend Structure and Price Action: NUKK continues to trade within a dominant long-term downtrend, with price near USD 3.8, well below prior highs and key resistance zones. Recent sideways movement reflects stabilization at low levels, but the lack of higher lows indicates consolidation rather than a confirmed trend reversal, keeping the broader bias cautious.
• Moving Averages and Trend Signals: The stock remains below both the 21-day (~USD 4.37) and 50-day (~USD 5.19) moving averages, with the short-term average below the long-term average, reinforcing a bearish-to-neutral trend configuration. Repeated failures near these averages suggest persistent overhead supply, limiting upside unless price decisively reclaims the 50-day average.
• Momentum, Support, and Risk Outlook: Momentum remains weak, with RSI around 40, indicating limited buying strength but not extreme oversold conditions. Volume remains modest, pointing to low institutional participation. Key support lies near USD 3.3–3.4, while USD 4.3–4.5 acts as immediate resistance; inability to break above resistance keeps the near-term risk skewed toward range-bound trading or renewed downside pressure.

Nukkleus Inc. (NASDAQ: NUKK) is currently positioned in a transitional phase, characterized by strategic repositioning toward artificial intelligence and defense-adjacent technologies alongside a temporary absence of operating revenues following the deconsolidation of its DRFQ subsidiary. During 2025, the Company initiated expansion into AI through its investment in Darwin tokens and entered the U.S. defense and homeland security ecosystem via an exclusive drone payload distribution agreement, though both initiatives remain in early-stage commercialization. Financial results for the period were marked by elevated professional and transaction-related expenses and headline profitability driven largely by non-cash fair value gains rather than operating cash generation, with operating cash flows remaining negative and a working capital deficit of approximately USD 30.5 million. Near-term fundamentals remain closely tied to the successful completion of the Star and Tiltan acquisitions, which management expects to unlock revenue visibility, normalize cost structures, and transition the business toward sustainable operations. From a technical perspective, the stock continues to trade below key moving averages within a broader downtrend, indicating that while price action has stabilized at lower levels, market conviction remains cautious pending clearer evidence of operational execution and revenue inflection.

As per the above-mentioned price action, important resistance near USD 4.00- USD 4.40, momentum in the stock over the last month, and technical indicators analysis, a ‘WATCH’ rating has been given for Nukkleus Inc. (NASDAQ: NUKK), at the closing price of USD3.81, as of January 12, 2026.

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective, and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is January 12, 2026. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.